Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: A simulation study

被引:97
作者
Stolk, WA
Swaminathan, S
van Oortmarssen, GJ
Das, PK
Habbema, JDF
机构
[1] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands
[2] Indian Council Med Res, Vector Control Res Ctr, Pondicherry, India
关键词
D O I
10.1086/378354
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
LYMFASIM, a microsimulation model for transmission and control of lymphatic filariasis, was used to simulate the effects of mass treatment, in order to estimate the number of treatment rounds necessary to achieve elimination. Simulations were performed for a community that represented Pondicherry, India, and that had an average precontrol microfilariae (MF) prevalence of 8.5%. When ivermectin was used, 8 yearly treatment rounds with 65% population coverage gave a 99% probability of elimination. The number of treatment rounds necessary to achieve elimination depended to a large extent on coverage, drug efficacy, and endemicity level. Changing the interval between treatment rounds mainly influenced the duration of control, not the number of treatment rounds necessary to achieve elimination. Results hardly changed with alternative assumptions regarding the type of immune mechanism. The potential impact of mass treatment with a combination of diethylcarbamazine and albendazole is shown under different assumptions regarding its efficacy. Human migration and drug resistance were not considered. Results cannot be directly generalized to areas with different vector or epidemiological characteristics. In conclusion, the prospects for elimination of bancroftian filariasis by mass treatment in Pondicherry seem good, provided that the level of population coverage is sufficiently high.
引用
收藏
页码:1371 / 1381
页数:11
相关论文
共 53 条
[1]  
[Anonymous], 2000, STAT CONFIDENCE
[2]  
Balakrishnan N, 1992, J Commun Dis, V24, P87
[3]   Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes [J].
Bockarie, MJ ;
Alexander, NDE ;
Hyun, P ;
Dimber, Z ;
Bockarie, F ;
Ibam, E ;
Alpers, MP ;
Kazura, JW .
LANCET, 1998, 351 (9097) :162-168
[4]   Ivermectin: effectiveness in lymphatic filariasis [J].
Brown, KR ;
Ricci, FM ;
Ottesen, EA .
PARASITOLOGY, 2000, 121 :S133-S146
[5]  
Cao WC, 1997, TROP MED INT HEALTH, V2, P393
[6]   WUCHERERIA-BANCROFTI INFECTION IN HUMAN AND MOSQUITO POPULATIONS OF A POLYNESIAN VILLAGE 10 YEARS AFTER INTERRUPTION OF MASS CHEMOPROPHYLAXIS WITH DIETHYLCARBAMAZINE [J].
CARTEL, JL ;
NGUYEN, NL ;
SPIEGEL, A ;
MOULIAPELAT, JP ;
PLICHART, R ;
MARTIN, PMV ;
MANUELLAN, AB ;
LARDEUX, F .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (04) :414-416
[7]   Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India [J].
Das, PK ;
Ramaiah, KD ;
Vanamail, P ;
Pani, SP ;
Yuvaraj, J ;
Balarajan, K ;
Bundy, DAP .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (03) :336-341
[8]   AGE-SPECIFIC ACQUISITION OF IMMUNITY TO INFECTIVE LARVAE IN A BANCROFTIAN FILARIASIS ENDEMIC AREA OF PAPUA-NEW-GUINEA [J].
DAY, KP ;
GREGORY, WF ;
MAIZELS, RM .
PARASITE IMMUNOLOGY, 1991, 13 (03) :277-290
[9]   DIRECT ASSESSMENT OF THE ADULTICIDAL EFFICACY OF A SINGLE-DOSE OF IVERMECTIN IN BANCROFTIAN FILARIASIS [J].
DREYER, G ;
NOROES, J ;
AMARAL, F ;
NEN, A ;
MEDEIROS, Z ;
COUTINHO, A ;
ADDISS, D .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (04) :441-443
[10]   Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination:: evaluation of the potential for control at 12 months after treatment [J].
Dunyo, SK ;
Nkrumah, FK ;
Simonsen, PE .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (04) :437-443